动物用皮肤科治疗药市场:药物的各类型，动物的各类型，各地区-规模，占有率，展望，机会分析，2023～2030年

兽医皮肤病药物是用于治疗动物皮肤病的药物。这些药物配製用于治疗皮肤癌、细菌感染和寄生虫感染。加强兽医医疗服务的出现使兽医能够为各种慢性和传染病提供广泛的治疗选择。这些技术使兽医医疗服务对兽医和宠物主人来说都更加方便和具有成本效益。

由于宠物主人对动物健康的认识不断提高，预计未来兽用皮肤病药物市场将出现显着成长。此外，寄生虫栖息地的生态变化，气候变化，媒介与宿主相互作用增加，外来物种在流行区的导入以及传统流行区以外媒介传播感染的高风险也有望推动全球兽医皮肤病学的发展。药品市场成长。此外，更好的分子诊断和治疗技术的进步有望进一步推动兽医皮肤病药物市场的成长。

相反，严格的审批规定和与药物相关的副作用预计会限制市场成长。

目录

第1章 调查目的与前提条件

• 调查目的
• 前提条件
• 简称

第2章 市场展望

• 报告概要
  • 市场定义和范围
• 摘要整理
  • 市场概述:药物的各类型
  • 市场概述:各动物类型
  • 市场概述:各地区
• Coherent Opportunity Map(COM)

第3章 市场动态，法律规章，趋势分析

• 市场动态
  • 促进因素
• 动物的皮肤疾病增加
• 宠物饲主数增加
  • 阻碍因素
• 新兴各国的认知度低
• 医药品相关的副作用
• 严格的核准法规
  • 商机
• 政府及民营企业投资增加
• 最尖端的治疗方法的开发
• 影响度分析
• 主要的焦点
• 法规情境
• 产品销售/核准
• PEST分析
• PORTER的分析
• 合併、收购情境

第4章 动物用皮肤科治疗药的全球市场- 冠状病毒(COVID-19)的大流行的影响

• COVID-19流行病学调查
• 供给侧和需求侧的分析
• 经济影响

第5章 动物用皮肤科治疗药的全球市场，药物的各类型，2017年～2030年

• 抗菌药
• 抗真菌药物
• 抗发炎药
• 免疫疗法药
• 寄生虫驱除剂
• 其他

第6章 动物用皮肤科治疗药的按全球市场，动物物种，2017年～2030年

• 狗
• 猫
• 马
• 其他

第7章 动物用皮肤科治疗药的全球市场，各地区，2017年～2030年

• 北美
• 欧洲
• 亚太地区
• 南美
• 中东、非洲地区

第8章 竞争情形

• Zoetis Inc.
• Elanco Animal Health Incorporated
• Boehringer Ingelheim International GmbH
• Virbac
• Vetoquinol S.A.
• Dechra Pharmaceuticals PLC
• Bayer AG
• Ceva Sante Animale
• Kindred Biosciences, Inc.
• IDEXX Laboratories, Inc.

第9章 Section

• 关于调查手法
• 关于出版社

Veterinary dermatology drugs are therapeutics used for the treatment of skin diseases in animals. These drugs are formulated to treat skin cancer, bacterial infections, and parasitic infestations. The emergence of enhanced veterinary medical services has enabled veterinarians to offer a wide range of treatment options for various chronic and infectious diseases. These technologies have made veterinary medical services more convenient and cost-effective for both veterinarians and pet owners.

Market Dynamics:

The veterinary dermatology drugs market is expected to witness significant growth in the future due to the rising awareness about animal health among pet owners. Additionally, changes in the ecology of parasite habitat, climate change, increase in vector-host interactions, the introduction of foreign species in endemic areas, and high risk of vector-borne infection outside traditional endemic areas are also expected to drive the global veterinary dermatology drugs market growth. Moreover, advancements in technology for better molecular diagnostics and treatments are further anticipated to propel veterinary dermatology drug market growth.

On the contrary, strict approval regulations and side effects associated with the drugs are expected to restrict market growth.

Key features of the study:

• This report provides in-depth analysis of the global veterinary dermatology drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary dermatology drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac, Vetoquinol S.A., Dechra Pharmaceuticals PLC, Bayer AG, Ceva Sante Animale, Kindred Biosciences, Inc., and IDEXX Laboratories, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global veterinary dermatology drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary dermatology drugs market

Detailed Segmentation:

• Global Veterinary Dermatology Drugs Market, By Type of Drug:
  • Antibiotics
  • Antifungal drugs
  • Anti-inflammatory drugs
  • Immunotherapy drugs
  • Parasiticides
  • Others
• Global Veterinary Dermatology Drugs Market, By Animal Type:
  • Dogs
  • Cats
  • Horses
  • Others
• Global Veterinary Dermatology Drugs Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Bayer AG
  • Ceva Sante Animale
  • Kindred Biosciences, Inc.
  • IDEXX Laboratories, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type Of Drug
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Growing prevalence of skin disease in animals
• Rise in number of pet owners
  • Restraints
• Lack of awareness across developing countries
• Side-effects associated with drugs
• Strict approval regulations
  • Opportunities
• Increasing investment by government and private sectors
• Development of cutting-edge therapies
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Veterinary Dermatology Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Veterinary Dermatology Drugs Market , By Type of Drug, 2017-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Antifungal drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Anti-inflammatory drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Immunotherapy drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Parasiticides
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

6. Global Veterinary Dermatology Drugs Market , By Animal Type, 2017-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Dogs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
• Cats
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
• Horses
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Billion)

7. Global Veterinary Dermatology Drugs Market , By Region, 2017-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2017 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type Of Drug, 2017-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017-2030,(US$ Bn)

8. Competitive Landscape

• Zoetis Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Elanco Animal Health Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Boehringer Ingelheim International GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Virbac
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Vetoquinol S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Dechra Pharmaceuticals PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ceva Sante Animale
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Kindred Biosciences, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• IDEXX Laboratories, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

9. Section

• Research Methodology
• About us